Geneos Wealth Management Inc. Bluebird Bio, Inc. Transaction History

Geneos Wealth Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $4,395 - $11,448	-1,080 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$8.96 - $16.31 $8,762 - $15,951	978 Added 958.82%	1,080 $10,000
Q3 2019 Sep 07, 2021	SELL	$59.47 - $93.1 $3,270 - $5,120	-55 Reduced 35.03%	102 $9,000
Q1 2019 Sep 07, 2021	SELL	$64.44 - $104.11 $4,188 - $6,767	-65 Reduced 29.28%	157 $24,000
Q2 2018 Sep 07, 2021	BUY	$99.64 - $127.59 $6,476 - $8,293	65 Added 41.4%	222 $34,000
Q4 2017 Sep 07, 2021	BUY	$81.25 - $130.7 $4,468 - $7,188	55 Added 53.92%	157 $27,000
Q3 2017 Sep 07, 2021	SELL	$57.74 - $91.42 $22,980 - $36,385	-398 Reduced 79.6%	102 $14,000
Q2 2017 Sep 07, 2021	BUY	N/A	500	500 $52,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.